Novavax to Participate in Multiple Investor Conferences in September
September 02 2015 - 4:31PM
GAITHERSBURG, Md., Sept. 02, 2015 (GLOBE NEWSWIRE)
-- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
the Company will participate in the FBR 2nd Annual Healthcare
Conference and the Citi 10th Annual Biotech Conference.
Conference details are as
follows:
FBR
2nd Annual Healthcare Conference
Date: Wednesday, September 9,
2015
Forum: One-on-one meetings
Location: Four Seasons Hotel, Boston
Citi
10th Annual Biotech Conference
Date: Thursday, September 10,
2015
Forum: Panel discussion, Preventing and
Treating Viral Infections: Vaccines and Antivirals
Time: 8:00 - 8:55 a.m. US Eastern Time
Location: Mandarin Oriental Hotel, New York
About
Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage vaccine company committed to delivering novel
products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for groundbreaking innovation that improves global
health through safe and effective vaccines. Additional information
about Novavax is available on the company's
website, novavax.com.
Contact: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#1949392
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024